The daily practice reality of PD‑L1 (CD274) evaluation in non‑small cell lung cancer: A retrospective study-Reference-Cited by-同舟云学术

The daily practice reality of PD‑L1 (CD274) evaluation in non‑small cell lung cancer: A retrospective study

Published:2020-03-12 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Verocq Camille¹,Decaestecker Christine²,Rocq Laureen¹,De Clercq Sarah¹,Verrellen Audrey¹,Mekinda Zita³,Ocak Sebahat⁴,Comp�re Christophe⁵,Stanciu‑Pop Claudia⁶,Salmon Isabelle¹,Remmelink Myriam¹,D'Haene Nicky¹

Affiliation:

1. Department of Pathology, Erasme Hospital, Universit� Libre de Bruxelles (ULB), 1070 Brussels, Belgium

2. DIAPath‑Center for Microscopy and Molecular Imaging, ULB, 6041 Gosselies, Belgium

3. Department of Pulmonology, Erasme Hospital, ULB, 1070 Brussels, Belgium

4. Division of Pulmonology, Centre Hospitalier Universitaire (CHU) Universit� Catholique de Louvain (UCL) Namur (Godinne Site), UCL, 5530 Yvoir, Belgium

5. Department of Pulmonology, Centre Hospitalier Inter R�gional Edith Cavell Cancer Institute, 1160 Brussels, Belgium

6. Department of Pathology, CHU UCL Namur (Godinne Site), UCL, 5530 Yvoir, Belgium

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Program death ligand‐1 immunocytochemistry in lung cancer cytological samples: A systematic review;Diagnostic Cytopathology;2022-03-16

2. Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer;Medicine;2021-05-21

3. Response;Chest;2020-10

4. RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens;Biomedicines;2020-05-09